Gain Therapeutics (GANX) - Kapitalizatsiyaning foydaga nisbati

Gain Therapeutics Inc. (GANX) korporativ emblemasi va logotipi

Gain Therapeutics, Inc. (GANX) AI platformlari va robotlashtirilgan molekulalarni skrining qilish orqali neyrodegenerativ patologiyalar uchun davolash vositalarini kashf etishni avtomatlashtiradi. Tijoriy savdolarning yo'qligi va tashqi moliyalashtirishga bog'liqlik pul oqimlarini oldindan aAniqlab bo'lmaydigan holga keltirmoqda. Ushbu narx harakati -2.30 miqdoridagi bozor bahosini aks ettiradi. Jori o'sish Parkinson kasalligi tadqiqotlari uchun berilgan grantlar bilan qo'llab-quvvatlanmoqda, sinovlarning erta bosqich natijalari kutilishi esa kelajakdagi katalizator vazifasini o'taydi.

Gain Therapeutics Inc. - GANX Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 17.11.2026)

gaintherapeutics.com (GANX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:Gain Therapeutics, Inc.
Gain Therapeutics, Inc. seriyali mahsuloti

Proteinlarni nishonga olgan holda Parkinson kasalligiga qarshi kurashishning noyob usullarini ishlab chiqayotgan Gain Therapeutics, Inc. (GANX) uchun biznesning rentabelliga nisbatan baholanishi muhim samaradorlik filtri hisoblanadi. Kompaniyaning tuzatilgan P/E koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasini sof foyda bilan solishtiradi, bu esa aktivning haddan tashqari qimmat baholanganligini aniqlash va yuqori xavfli tibbiy ishlanmalarga kiritilgan investitsiyalar asosli ekanligini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Kapitalizatsiyaning foydaga nisbati hcahealthcare.com HCA|Narxning foydaga nisbati Tenet Healthcare (THC)|Fresenius Medical Care - Narx-foyda multiplikatori|Narxning foydaga nisbati Solventum SOLV|Bozor narxining sof foydaga nisbati EHC (Encompass Health)|UHS: Narx-foyda koeffitsiyenti|DVA (DaVita) - Narx-foyda multiplikatori|RadNet Corp (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Option Care Corp (OPCH)|Narx-foyda koeffitsiyenti SGRY|PINC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EYE|PGNY - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ARDT (ardenthealth.com)|SEM - Narx-foyda koeffitsiyenti|Astrana Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E multiplikatori|NUTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AUNA|Narx-foyda koeffitsiyenti SBC Medical Group Holdings Inc SBC|Narxning foydaga nisbati Jeuveau EOLS|Kompaniya qiymatining sof foydaga nisbati CYH|SKIN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati MDWD (MediWound)|BTMD (biote.com) - Narx-foyda koeffitsiyenti|Narx-foyda koeffitsiyenti thejoint.com|DCGO (DocGo, Inc.) - P/E multiplikatori|Narxning foydaga nisbati PIII|Narx-foyda koeffitsiyenti EUDA (EUDA Health Holdings)|Narxning foydaga nisbati BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Narx-foyda koeffitsiyenti|CUPR: Narx-foyda multiplikatori|CCM: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AMS (American Shared Hospital Services)|MRM: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalon GloboCare Corp (ALBT)|Narxning foydaga nisbati DIH Holding|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|P/E multiplikatori ATI Physical Therapy Inc. (ATIP)|P/E multiplikatori CMAX (caremax.com)|Bozor narxining sof foydaga nisbati KDLY (Kindly Health)|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati novointegrated.com|SunLink Health Systems (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti IMAC Holdings Inc